Q78.2
Osteopetrosis
Clinical Classification Guidelines
Inclusion Terms
- Albers-Schönberg syndrome
- Osteosclerosis NOS
Medical Intelligence & Overview
Osteopetrosis, also known as Albers-Schönberg syndrome, is a rare genetic bone disorder characterized by increased bone density and abnormal bone growth. This condition results from a defect in the cells responsible for breaking down old bone tissue, leading to overly dense but fragile bones. While the bones become thicker and heavier, they can also become more susceptible to fractures and other complications. Understanding this condition is vital for recognizing its signs and exploring management options.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting osteoclast function, leading to impaired bone resorption Inheritance patterns can be autosomal dominant or autosomal recessive, influencing severity Mutations in specific genes such as TCIRG1, CLCN7, and others associated with bone remodeling processes
Key Symptoms: Bone pain and tenderness Frequent fractures due to brittle bones despite increased density Delayed growth and developmental delays in children Skeletal abnormalities, including skull deformities and enlarged jawbones Vision and hearing problems due to nerve compression from thickened skull bones Hematologic issues like anemia resulting from marrow cavity narrowing Recurrent infections stemming from reduced marrow space
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation and specialized tests. X-rays typically reveal unusually dense bones with characteristic patterns. Blood tests may show low levels of normal blood cells. Genetic testing can identify specific mutations associated with the disease. Additional assessments like bone marrow examinations and nerve conduction studies may help determine complications related to nerve compression and marrow function.
Treatment Protocols: Monitoring and managing fractures promptly Bone marrow transplants in severe cases to improve marrow function and bone health Medications like calcitriol or interferon gamma to stimulate bone resorption Rehabilitative therapies to support mobility and function Surgical interventions to correct bone deformities or relieve nerve compression Regular follow-up with healthcare providers to monitor disease progression
Clinical Advice & FAQs
Billing Guidance
Is Q78.2 a billable ICD-10 code?
Yes, Q78.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q78.2?
Clinical documentation must specify the nature of Osteopetrosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference